Phathom Pharmaceuticals (PHAT)CFO sold ~$17K
Molly Henderson, CFO at Phathom Pharmaceuticals, sold ~$17K of Phathom Pharmaceuticals shares.
- ~$17K
- Approx. value · 3,678 sh @ $4.55
- 90K
- Holds after · shares reported
- Traded
- Apr 7, 2025
- Filed
- Apr 8, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 13, 2025InsiderDirector purchased ~$44K of PHAT shares in the open market
- Apr 7, 2025 · this disclosureInsiderCFO sold ~$17K of PHAT shares in the open market
What came next
- May 6, 2025InsiderDirector purchased ~$13K of PHAT shares in the open market
- May 7, 2025InsiderDirector purchased ~$12K of PHAT shares in the open market
- May 9, 2025Insider · 1 personInsiders: 2 purchases (~$115K)
- May 12, 2025InsiderDirector purchased ~$38K of PHAT shares in the open market
- May 13, 2025InsiderDirector purchased ~$3.5K of PHAT shares in the open market
- May 14, 2025InsiderDirector purchased ~$21K of PHAT shares in the open market
- May 21, 2025InsiderDirector purchased ~$15K of PHAT shares in the open market
- Jul 16, 2025InsiderOfficer sold ~$14K of PHAT shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Phathom Pharmaceuticals
OQRO holds no insider, Congress, fund or contract record for Phathom Pharmaceuticals dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PHAT page.
Other recent filings by Molly Henderson, CFO and CBO
- SEC Form 4 at Phathom Pharmaceuticals (PHAT)Jan 23, 2025
- SEC Form 4 at Phathom Pharmaceuticals (PHAT)Dec 20, 2024
The full history of Molly Henderson, CFO and CBO is on the profile page.
How this filing works
Other disclosures at Phathom Pharmaceuticals
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HROct 20, 2025
- SEC Form 4Sep 9, 2025
- SEC Form 13F-HRAug 14, 2025
- SEC Form 13F-HRAug 7, 2025
Everything OQRO holds on this company is on its PHAT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
